Clinical Trial Update: Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety update on a combination therapy (AMG 706 + panitumumab + gemcitabine-cisplatin) for advanced cancers; the trial status is terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• AMG 706 (motesanib)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Lung Cancer, Pancreatic Cancer | Phase 1 | Status: TERMINATED | Results posted: 2014-03-20